1. Volume 66, Issue 6, Pages 1190-1193 (December 2014)
Re: Antibody-drug Conjugates Targeting Prostate-specific Membrane Antigen 
Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, Marina Scarpelli, Roberta Mazzucchelli, Francesco Montorsi 
European Urology 
Volume 66, Issue 6, Pages (December 2014)
DOI: /j.eururo
Copyright © Terms and Conditions

2. Fig. 1
(a) Strong and diffuse prostate-specific antigen (PSA) immunostaining in a Gleason 3+3=6 acinar adenocarcinoma; (b) lack of PSA immunostaining in the bone metastasis of a solid prostate cancer (this represents the progression stage of the patient whose initial adenocarcinoma is shown in (a); (c) weak and focal prostate-specific membrane antigen (PSMA) immunostaining (the same tumor as in [a]); (d) strong and diffuse PSMA immunostaining, mostly at the cell membrane level (the same tumor as in [b]).
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions